Organon

Yahoo Finance • 13 hours ago

3 Reasons to Avoid OGN and 1 Stock to Buy Instead

Over the last six months, Organon’s shares have sunk to $9.03, producing a disappointing 5.9% loss - a stark contrast to the S&P 500’s 2.5% gain. This may have investors wondering how to approach the situation. Is now the time to buy Orga... Full story

Yahoo Finance • 2 days ago

Organon (OGN) Climbs 39% on $12-Billion Merger Buzz

Organon & Co. (NYSE:OGN) is one of the 10 Stocks Powering Portfolios by Double Digits. Organon surged by 38.8 percent week-on-week, as investors gobbled up shares following reports that it is set to be acquired by Sun Pharmaceutical Indus... Full story

Yahoo Finance • 3 days ago

Trending stocks this week as ceasefire hopes lift sentiment amid U.S.-Israel-Iran Tensions

Wall Street’s main indexes posted weekly gains this week as investors digested hopes of a ceasefire deal between the U.S. and Israel and Iran’s regime. For the week, the S&P gained 3.6%, while the tech-heavy Nasdaq Composite rose 4.7%, and... Full story

Yahoo Finance • 3 days ago

Morning Movers: Organon jumps after report of Sun Pharmaceutical bid

Stock futures are essentially flat, reflecting a market waiting for confirmation. Markets are ending the week in a cautious holding pattern, with momentum from earlier in the week fading. Easter Sale - 70% Off TipRanks Unlock hedge fund... Full story

Yahoo Finance • 4 days ago

Sector Update: Health Care Stocks Fall Late Afternoon

Health care stocks declined late Friday afternoon, with the NYSE Health Care Index falling 1.1% and PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 4 days ago

Organon Jumps 25% As Report Cites $12 Billion Sun Pharma Offer

This article first appeared on GuruFocus. Shares of Organon (NYSE:OGN) surged sharply on Friday after a report indicated that Sun Pharmaceutical Industries had submitted a binding $12 billion all-cash offer for the women's healthcare comp... Full story

Yahoo Finance • 4 days ago

Sector Update: Health Care Stocks Lower Friday Afternoon

Health care stocks declined Friday afternoon, with the NYSE Health Care Index decreasing 0.7% and th PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 4 days ago

Top Midday Stories: CoreWeave to Provide AI Cloud Capacity for Anthropic; TSMC Q1 Net Revenue Rises

The S&P 500 and Nasdaq Composite were up, while the Dow Jones Industrial Average was down in late-mo PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 5 days ago

Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty

VANCOUVER, BC / ACCESS Newswire / April 9, 2026 / (TSXV:OGN)(OTCQB:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce an update to the Mineral Reserve and Resource estimates on the Ermitaño concession within Fi... Full story

Yahoo Finance • 14 days ago

Organon Highlights VTAMA Data And Women’s Health Grants As Shares Struggle

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Organon (NYSE:OGN) presented new post hoc analysis from Phase 3 trials of VTAMA cream for atopic... Full story

Yahoo Finance • 21 days ago

Organon: A High Cash Yield Hidden Behind Patent Fatigue

This article first appeared on GuruFocus. Introduction Organon is an American pharmaceutical company spun off from Merck & Co. in 2021 with a focus on women's health, biosimilars, and established brands. Headquartered in Jersey City, it... Full story

Yahoo Finance • 27 days ago

Organon leads ultra-low P/E stocks at 1.8x as small-cap stocks face volatility

[Black Bull and Bear] peterschreiber.media/iStock via Getty Images Small-cap outperformance has narrowed over the last couple of weeks as investor caution increased, with volatility and geopolitical risk weighing on risk appetite and narr... Full story

Yahoo Finance • 29 days ago

Alger Russell Innovation Index Updates for First Quarter 2026

NEW YORK, March 16, 2026 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the clos... Full story

Yahoo Finance • 2 months ago

Fiserv Inc: A Significant Move in Jeff Auxier's Portfolio

This article first appeared on GuruFocus. Exploring the Strategic Investment Decisions of a Renowned Value Investor Jeff Auxier (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, providing insights into... Full story

Yahoo Finance • 2 months ago

Organon (OGN) Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. Date Feb. 12, 2026 at 8:30 a.m. ET Call participants Interim Chief Executive Officer — Joseph Morrissey Chief Financial Officer — Matthew Walsh Board Chair — Carrie Cox Head of R&D — Juan Camilo Arjona Fe... Full story

Yahoo Finance • 2 months ago

Organon Q4 Earnings Preview: Cautious view amid weak year

[Female doctor and senior woman looking at digital tablet in exam room] MoMo Productions Organon (OGN [https://seekingalpha.com/symbol/OGN]) is scheduled to announce Q4 earnings results on Thursday, February 12th, before market open. The... Full story

Yahoo Finance • 5 months ago

Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US

SHANGHAI and JERSEY CITY, N.J., Nov. 17, 2025 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (... Full story

Yahoo Finance • 5 months ago

Insider trades: Boeing, Starbucks, Merck among notable names this week

[Close-up of male professional hands using mobile phone] Luis Alvarez This week, insider trading was seen across companies like Nike (NKE [https://seekingalpha.com/symbol/NKE]), Boeing (BA [https://seekingalpha.com/symbol/BA]) and Merck (... Full story

Yahoo Finance • 5 months ago

Interim Report - January-September 2025

Karolinska Development AB (publ) STOCKHOLM – 14 November 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report January-September 2025. The full report is available on the Company's website. “We are n... Full story

Yahoo Finance • 5 months ago

Organon cuts outlook despite Q3 beat amid JADA divestment

[Rolled newspaper with the headline Quarterly Results] Zerbor/iStock via Getty Images Organon (OGN [https://seekingalpha.com/symbol/OGN]) shares added ~3% in the premarket on Monday, even as the women’s health company lowered its full-yea... Full story